MBC BioLabs Announces New Partnership with Opentrons

[San Francisco, CA – August 7, 2025] – MBC BioLabs is excited to announce the start of a new partnership with Opentrons Labworks. This collaborative partnership will help support the mission of enabling awesome for MBC BioLabs’ community of high-growth biotech start-up companies.

About Opentrons

Opentrons Labworks, Inc., is a disruptive life science company accelerating innovation in research and healthcare through its integrated lab platform. Opentrons has raised over $200 million in funding and achieved unicorn status based on its innovative technologies. The Opentrons Flex® is Opentrons’ newest generation of liquid-handling lab robots, offering accessibility and compatibility with generative AI tools. Opentrons Robotics provides thousands of institutions with flexible, easy-to-use lab robots, automating R&D operations and making a vast open-source protocol library accessible to life sciences researchers worldwide. Opentrons is used in labs at the top 20 academic universities in the US and 14 of 15 leading global biopharmaceutical companies. Learn more at https://opentrons.com/

About MBC BioLabs
At MBC BioLabs, we believe that startups are the greatest force for positive change in the world. We are dedicated to helping biotech startups succeed – we like to say that we enable awesome. We offer flexible and cost-effective lab space, complete with operational support and millions of dollars’ worth of state-of-the-art equipment and instrumentation, along with a vibrant community of like-minded individuals tackling the world’s biggest problems.

We have helped launch and grow over 500 companies since opening in October of 2013, and together, MBC companies have initiated 176 clinical trials, introduced 135 products to market, and collectively raised over $20 billion. Learn more at mbcbiolabs.com.